{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T14:30:45Z","timestamp":1775053845098,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["21200122"],"award-info":[{"award-number":["21200122"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["COVID19F05"],"award-info":[{"award-number":["COVID19F05"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["06200097"],"award-info":[{"award-number":["06200097"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["CID-HKU2"],"award-info":[{"award-number":["CID-HKU2"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["PER00098"],"award-info":[{"award-number":["PER00098"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.cmi.2024.10.007","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T11:07:52Z","timestamp":1728731272000},"page":"625-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immuno-persistence after the fourth and fifth doses of inactivated polio vaccines in school-aged children"],"prefix":"10.1016","volume":"31","author":[{"given":"Kathy","family":"Leung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrissy W.K.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany H.K.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Vargas-Zambrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommy T.Y.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric H.Y.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph T.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2024.10.007_bib1","series-title":"Global polio eradication initiative 2023 [Internet]","year":"2023"},{"key":"10.1016\/j.cmi.2024.10.007_bib2","series-title":"Polio eradication and endgame strategic plan 2013\u20132018 [Internet]","year":"2013"},{"key":"10.1016\/j.cmi.2024.10.007_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000244","article-title":"Assessing the characteristics of un-and under-vaccinated children in low-and middle-income countries: a multi-level cross-sectional study","volume":"2","author":"Utazi","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"10.1016\/j.cmi.2024.10.007_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12992-016-0195-3","article-title":"Eradicating polio in Pakistan: an analysis of the challenges and solutions to this security and health issue","volume":"12","author":"Hussain","year":"2016","journal-title":"Glob Health"},{"key":"10.1016\/j.cmi.2024.10.007_bib5","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.4269\/ajtmh.20-1010","article-title":"Polio in Afghanistan: the current situation amid COVID-19","volume":"103","author":"Ahmadi","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2024.10.007_bib6","series-title":"Childhood immunization begins recovery after COVID-19 backslide [Internet]","year":"2023"},{"key":"10.1016\/j.cmi.2024.10.007_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.49710","article-title":"Analysis of a Sabin-strain inactivated poliovirus vaccine response to a circulating type 2 vaccine-derived poliovirus event in Sichuan Province, China 2019-2021","volume":"6","author":"Yang","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cmi.2024.10.007_bib8","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(22)01875-X","article-title":"Polio eradication: falling at the final hurdle?","volume":"400","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2024.10.007_bib9","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/infdis\/jiad355","article-title":"Modeling poliovirus transmission and responses in New York State","volume":"229","author":"Thompson","year":"2024","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2024.10.007_bib10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(22)01582-3","article-title":"Emergence of vaccine-derived poliovirus in high-income settings in the absence of oral polio vaccine use","volume":"400","author":"Hill","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2024.10.007_bib11","first-page":"629","article-title":"Battle of polio eradication in the Western Pacific region in the transition to COVID-19 endemicity","volume":"86","author":"Mei","year":"2023","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2024.10.007_bib12","series-title":"Department of health of the government of the Hong Kong special administrative region. Updated Childhood Immunisation Programme to launch in 2007. [Internet]","year":"2006"},{"key":"10.1016\/j.cmi.2024.10.007_bib13","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1093\/infdis\/jiw574","article-title":"Experience with inactivated polio vaccine introduction and the \u201cswitch\u201d from trivalent to bivalent oral polio vaccine in the World Health Organization\u2019s Western Pacific region","volume":"216","author":"Gurung","year":"2017","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2024.10.007_bib14","series-title":"China will implement a new polio vaccine immunization strategy and incorporate inactivated polio vaccine into the national immunization schedule 2016-04-29 [Internet]","year":"2016"},{"key":"10.1016\/j.cmi.2024.10.007_bib15","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.46234\/ccdcw2021.270","article-title":"Childhood immunization schedule for national immunization program vaccines\u2014China (version 2021)","volume":"3","year":"2021","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.cmi.2024.10.007_bib16","series-title":"Shanghai will adjust the immunization schedule for polio vaccine and measles-containing vaccine 2020 [Internet]","year":"2022"},{"key":"10.1016\/j.cmi.2024.10.007_bib17","series-title":"Notice on adjusting the polio vaccination program starting from 1 Jan 2023 2022 [Internet]","year":"2022"},{"key":"10.1016\/j.cmi.2024.10.007_bib18","series-title":"Zhejiang Province is going to implement 4-dose inactivated vaccines for polio immunization programme 2023 [Internet]","year":"2023"},{"key":"10.1016\/j.cmi.2024.10.007_bib19","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.vaccine.2003.10.026","volume":"22","author":"Langue","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2024.10.007_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4161\/hv.6.2.10117","article-title":"Immunological persistence in 4-6 and 7-9 year olds previously vaccinated in infancy with hexavalent DTPa-HBV-IPV\/Hib","volume":"6","author":"Zinke","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.cmi.2024.10.007_bib21","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/es60130a004","article-title":"Trimmed Spearman-Karber method for estimating median lethal concentrations in toxicity bioassays","volume":"11","author":"Hamilton","year":"1977","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.cmi.2024.10.007_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102151","article-title":"Immune persistence of an inactivated poliovirus vaccine derived from the Sabin strain: a 10-year follow-up of a phase 3 study","volume":"64","author":"Ma","year":"2023","journal-title":"EClinicalmedicine"},{"key":"10.1016\/j.cmi.2024.10.007_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/tropej\/42.4.237","article-title":"Epidemiological considerations on age distribution of paralytic poliomyelitis","volume":"42","author":"Singh","year":"1996","journal-title":"J\u00a0Trop Pediatr"},{"key":"10.1016\/j.cmi.2024.10.007_bib24","first-page":"52","article-title":"Immunization","volume":"vol. 4","author":"Leung","year":"1999"},{"key":"10.1016\/j.cmi.2024.10.007_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1471-2458-14-133","article-title":"Chinese immigrant parents\u2019 vaccination decision making for children: a qualitative analysis","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.cmi.2024.10.007_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2023.105471","article-title":"Polio type 2 and 3 eradication: relevance to the immunity status of individuals living in Germany, 2005-2020","volume":"164","author":"Kohmer","year":"2023","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cmi.2024.10.007_bib27","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1128\/CVI.00054-12","article-title":"Seroepidemiology of polioviruses among university students in northern Italy","volume":"19","author":"Baldo","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cmi.2024.10.007_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00430-007-0036-3","article-title":"Seroprevalence of vaccine preventable and blood transmissible viral infections (measles, mumps, rubella, polio, HBV, HCV and HIV) in medical students","volume":"196","author":"Wicker","year":"2007","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.cmi.2024.10.007_bib29","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.2807\/esm.12.06.00717-en","article-title":"Seroprevalence of antibodies to poliovirus in individuals living in Portugal, 2002","volume":"12","author":"Pires de Miranda","year":"2007","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2024.10.007_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/vim.2006.0071","article-title":"Long-lasting poliovirus-neutralizing antibodies among Argentinean population immunized with four or five oral polio vaccine doses 1 month to 19 years previously","volume":"20","author":"Nates","year":"2007","journal-title":"Viral Immunol"},{"key":"10.1016\/j.cmi.2024.10.007_bib31","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.vaccine.2009.02.042","article-title":"Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: implications for future polio vaccination strategies","volume":"27","author":"P\u00edrez","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2024.10.007_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.trstmh.2010.05.004","article-title":"Monitoring of poliovirus neutralizing antibodies in S\u00e3o Paulo State, Brazil","volume":"104","author":"Luchs","year":"2010","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.cmi.2024.10.007_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2334-12-24","article-title":"Deficiency of immunity to poliovirus type 3: a lurking danger?","volume":"12","author":"Reinheimer","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2024.10.007_bib34","series-title":"Case report is it or is it not vaccine-associated paralytic poliomyelitis: a case report of acute flaccid paralysis after oral polio vaccine booster dose. HK J Paediatr (new Series)","first-page":"105","volume":"21","author":"Chung","year":"2016"},{"key":"10.1016\/j.cmi.2024.10.007_bib35","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.47.19723-en","article-title":"Type 1 wild poliovirus and putative enterovirus 109 in an outbreak of acute flaccid paralysis in Congo, October-November 2010","volume":"15","author":"Grard","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cmi.2024.10.007_bib36","doi-asserted-by":"crossref","first-page":"12889","DOI":"10.1073\/pnas.1323502111","article-title":"Robustness against serum neutralization of a poliovirus type 1 from a lethal epidemic of poliomyelitis in the Republic of Congo in 2010","volume":"111","author":"Drexler","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cmi.2024.10.007_bib37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.virusres.2015.11.025","article-title":"Antibody titers against vaccine and contemporary wild poliovirus type 1 in children immunized with IPV+OPV and young adults immunized with OPV","volume":"213","author":"Lukashev","year":"2016","journal-title":"Virus Res"},{"key":"10.1016\/j.cmi.2024.10.007_bib38","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.vaccine.2023.01.031","article-title":"Antigenic diversity of type 1 polioviruses and its implications for the efficacy of polio vaccines","volume":"41","author":"Kouiavskaia","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2024.10.007_bib39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41467-019-14174-2","article-title":"Deconvolving mutational patterns of poliovirus outbreaks reveals its intrinsic fitness landscape","volume":"11","author":"Quadeer","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2024.10.007_bib40","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S1473-3099(19)30738-8","article-title":"Immunogenicity of three sequential schedules with Sabin inactivated poliovirus vaccine and bivalent oral poliovirus vaccine in Zhejiang, China: an open-label, randomised, controlled trial","volume":"20","author":"He","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2024.10.007_bib41","article-title":"Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus vaccine in children aged 4 years: an open-label, randomised, controlled phase 4 trial in China","volume":"34","author":"Tang","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.cmi.2024.10.007_bib42","series-title":"Notice on carrying out catch-up vaccination with the second dose of inactivated polio vaccine for the relevant population 30-1-2024 [Internet]","year":"2024"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24004890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24004890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:11:28Z","timestamp":1762366288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X24004890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1198743X24004890"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2024.10.007","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immuno-persistence after the fourth and fifth doses of inactivated polio vaccines in school-aged children","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2024.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.01.019","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}